Sweet Itch in Horses: The Complete Scientific Breakdown

Sweet itch, or Insect Bite Hypersensitivity (IBH), is the most common allergic skin disease in horses. It is a chronic, seasonal dermatitis caused by a Type I and Type IV hypersensitivity reaction to salivary proteins from biting midges (Culicoides spp.). The condition affects around 5–10% of horses in the UK and Europe, with imported Icelandic horses showing prevalence rates up to 30–60% when first exposed to midges. Once sensitised, affected horses typically experience recurrent episodes each year for life.

Diagram of midge bite causing allergic reaction in horse (sweet itch pathogenesis).

Sweet itch presents as intense itching, rubbing of the mane, tail, rump, and belly, hair loss, thickened skin, crusting, and often secondary bacterial infection. It is not simply a skin problem; it is an immune‑driven disorder that manifests in the skin.

The Biology Behind Sweet Itch in horses

Sweet itch is driven by both Type I (immediate, IgE‑mediated) and Type IV (delayed, T‑cell‑mediated) hypersensitivity reactions. The disease progresses through three major phases: sensitisation, effector reaction, and chronicity.

Phase 1 — Sensitisation

When a midge bites, salivary proteins enter the dermis. Skin dendritic cells (Langerhans cells) capture these proteins and transport them to local lymph nodes. In genetically susceptible horses, the immune system shifts toward a Th2‑dominant response, producing cytokines such as IL‑4, IL‑5, and IL‑13. These cytokines drive B‑cells to produce allergen‑specific IgE antibodies.

These IgE antibodies bind to high‑affinity FcεRI receptors on mast cells in the skin. At this point, the horse is sensitised — its mast cells are “armed” and ready to react aggressively on the next exposure.

mast cell details

How mast cell works

Phase 2 — Effector Reaction

On subsequent midge bites, the allergens cross‑link IgE on mast‑cell surfaces, triggering rapid degranulation. This releases:

• Histamine

• Leukotrienes

• Prostaglandins

• Proteases

• Pro‑inflammatory cytokines

These mediators cause vasodilation, swelling, redness, and intense pruritus. Eosinophils are recruited by IL‑5 and eotaxins, infiltrating the skin and releasing cytotoxic granules that worsen tissue damage. Sensory nerves become activated, amplifying the itch response.

This is the stage where horses rub themselves raw.

Effector Reaction in Equine Sweet Itch — allergen–IgE cross‑linking triggers mast‑cell degranulation, histamine release, eosinophil infiltration, vasodilation, and sensory‑nerve activation, producing intense pruritus.

Phase 3 — Chronicity

With repeated seasons, the condition deepens:

• The epidermis thickens (hyperplasia)

• The skin becomes leathery and folded (lichenification)

• The barrier weakens, allowing deeper allergen penetration

• Secondary bacterial infections develop

• Nerve endings become hypersensitive

• Both Type I and Type IV hypersensitivity reactions become involved

The horse now reacts faster, earlier, and more severely each year.

What Triggers Sweet Itch

The primary trigger is exposure to Culicoides midge saliva. Secondary triggers can include blackflies (Simulium) and stable flies (Stomoxys), though these are less common.

Environmental triggers include:

• Warm, humid weather

• Standing water

• Woodland edges

• Dawn and dusk turnout

• Poor airflow

• High midge density areas

What Escalates Sweet Itch

Sweet itch severity increases when several factors combine:

Repeated allergen exposure   More bites lead to more mast‑cell activation and deeper inflammation.

Skin barrier damage   Rubbing creates abrasions, allowing more allergens and bacteria to enter.

Secondary infection   Bacterial overgrowth amplifies inflammation and slows healing.

Systemic inflammatory load   Obesity, high sugar/starch diets, and poor omega‑3:6 balance increase baseline inflammation, worsening reactions.

Oxidative stress   Chronic inflammation generates reactive oxygen species (ROS), damaging skin cells and slowing recovery.

Genetic predisposition   Certain MHC haplotypes increase susceptibility, especially in Icelandic horses.

Which Pathways Are Compromised in Sweet Itch

Sweet itch disrupts multiple biological systems simultaneously:

• Immune regulation: Th2 skew, IgE overproduction, hyper‑reactive mast cells

• Histamine control: excessive histamine and leukotriene release

• Skin barrier integrity: weakened epidermis, micro‑fissures, increased permeability

• Neuro‑immune axis: sensitised nerves, amplified itch signalling

• Inflammation–oxidative loop: ROS damage, chronic inflammation, slow healing

These combined dysfunctions explain why sweet itch is so persistent and difficult to manage.

Compromised Biological Pathways in Equine Sweet Itch — immune dysregulation, histamine release, barrier damage, neuro‑immune sensitisation, and oxidative stress interact to create a self‑perpetuating cycle of inflammation and pruritus.

How Dr Silver Sweet Itch Support Helps (Mapped to Pathways)

Dr Silver Sweet Itch Support is formulated to target the same biological pathways that sweet itch disrupts. Instead of masking symptoms, it supports the internal systems that influence the horse’s response to allergens.

Supports immune balance   Helps moderate the Th2‑dominant immune profile associated with IBH.

Helps maintain normal histamine levels   Supports mast‑cell stability and reduces excessive mediator release.

Supports skin barrier repair   Provides nutrients associated with keratin, collagen, and epidermal lipid structure, helping strengthen the barrier.

Reduces oxidative stress   Antioxidant‑rich components help counter ROS and support tissue resilience.

Supports the gut–immune axis   A balanced hindgut contributes to more regulated immune responses, relevant in chronic allergic conditions.

Complements external management   Works alongside rugs, repellents, and turnout timing to reduce allergen load.

Dr Silver Equi Shield PRO

Scientific References

1. Curnow B, Darroch I. Approaching the future management of sweet itch (IBH). UK‑Vet Equine. 2022;6(2):56‑60.

2. O’Neill W et al. Immunopathogenesis of insect bite hypersensitivity in horses. Veterinary Dermatology.

3. University of Liverpool Equine Hospital. Sweet itch: clinical overview and management.

4. The British Horse Society (BHS). Sweet Itch – Signs, Causes, Management.

5. Schaffartzik A et al. Genetic predisposition and MHC associations in Icelandic horses with IBH.

6. Wilson AD et al. Cytokine profiles in horses with Culicoides hypersensitivity.